Having trouble accessing articles? Reset your cache.

Provecta: Phase I data

In an open-label, dose-escalation, U.S. Phase I trial in 3 patients,

Read the full 112 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE